Novel pathways in gonadotropin receptor signaling and biased agonism

Reviews in Endocrine and Metabolic Disorders

Volumn 12, Issue 4, 2011, Pages 259-274

  Ulloa Aguirre, Alfredo ^{a,b,c,d,e,f,g}   Crépieux, Pascale ^a,b,c,d   Poupon, Anne ^a,b,c,d   Maurel, Marie Christine ^a,b,c,d   Reiter, Eric ^a,b,c,d  

^a UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d IFCE   (France)

^e Le Studium   (France)

^f INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^g Apdo Postal 99 065   (Mexico)

Author keywords

Biased agonism; Folliclestimulating hormone; Gonadotropin; GPCR; Luteinizing hormone; Signaling

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FOLLITROPIN; FOLLITROPIN RECEPTOR; GLYCAN; GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE;

ARTICLE; GLYCOSYLATION; HUMAN; NONHUMAN; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALS; DRUG AGONISM; FEMALE; GONADOTROPINS; HUMANS; IMMUNOCONJUGATES; LIGANDS; MALE; MODELS, BIOLOGICAL; POLYSACCHARIDES; RECEPTORS, GONADOTROPIN; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 84855677885     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-011-9176-2     Document Type: Article

References (168)

1. Pierce JG, Parsons TF. Glycoprotein hormones: Structure and function. Annu Rev Biochem. 1981;50:465-95. (Pubitemid 12164355)
2. Ryan RJ, Keutmann HT, Charlesworth MC, McCormick DJ, Milius RP, Calvo FO, et al. Structure-function relationships of gonadotropins. Recent Prog Horm Res. 1987;43:383-429.
3. Ascoli M, Fanelli F, Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002;23(2):141-74.
4. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev. 1997;18(6):739-73. (Pubitemid 28009566)
5. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev. 2000;21 (5):551-83.
6. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: A review of structure/function relationships. Endocr Rev. 1985;6(3):371-99.
7. Sharpe RM. Intratesticular control of steroidogenesis. Clin Endocrinol. 1990;33(6):787-807.
8. Lunenfeld B. Historical perspectives in gonadotrophin therapy. Hum Reprod Update. 2004;10(6):453-67. (Pubitemid 39529879)
9. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27(2):170-207.
10. Ludwig M, Westergaard LG, Diedrich K, Andersen CY. Developments in drugs for ovarian stimulation. Best Pract Res Clin Obstet Gynaecol. 2003;17(2):231-47. (Pubitemid 36647983)
11. Vloeberghs V, Peeraer K, Pexsters A, D'Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol. 2009;23(5):691-709.
12. Loutradis D, Drakakis P, Milingos S, Stefanidis K, Michalas S. Alternative approaches in the management of poor response in controlled ovarian hyperstimulation (COH). Ann NY Acad Sci. 2003;997:112-9. (Pubitemid 38491065)
13. Loutradis D, Elsheikh A, Kallianidis K, Drakakis P, Stefanidis K, Milingos S, et al. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations. Arch Gynecol Obstet. 2004;270(4):223-6.
14. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst. 1983;71 (4):717-21. (Pubitemid 14232385)
15. Choi JH, Wong AS, Huang HF, Leung PC. Gonadotropins and ovarian cancer. Endocr Rev. 2007;28(4):440-61. (Pubitemid 46984827)
16. Argento M, Hoffman P, Gauchez AS. Ovarian cancer detection and treatment: Current situation and future prospects. Anticancer Res. 2008;28(5B):3135-8.
17. Radu A, Pichon C, Camparo P, Antoine M, Allory Y, Couvelard A et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med.363(17):1621-30.
18. Naz RK, Gupta SK, Gupta JC, Vyas HK, Talwar AG. Recent advances in contraceptive vaccine development: A mini-review. Hum Reprod. 2005;20(12):3271-83. (Pubitemid 41742501)
19. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet. 1997;15(2):201-4.
20. Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82(6):959-68.
21. Foresta C, Selice R, Garolla A, Ferlin A. Follicle-stimulating hormone treatment of male infertility. Curr Opin Urol. 2008;18 (6):602-7.
22. Tuvemo T. Treatment of central precocious puberty. Expert Opin Investig Drugs. 2006;15(5):495-505.
23. Lenzi A, Balercia G, Bellastella A, Colao A, Fabbri A, Foresta C, et al. Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. J Endocrinol Investig. 2009;32(11):934-8.
24. Ma P, Zemmel R. Value of novelty? Nat Rev Drug Discov. 2002;1(8):571-2.
25. Stephenson RP. A modification of receptor theory. Br J Pharmacol Chemother. 1956;11(4):379-93.
26. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, et al. Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther. 2007;320 (1):1-13. (Pubitemid 46025713)
27. Violin JD, Lefkowitz RJ. Beta-arrestin-biased ligands at seventransmembrane receptors. Trends Pharmacol Sci. 2007;28 (8):416-22.
28. Kenakin T. New concepts in drug discovery: Collateral efficacy and permissive antagonism. Nat Rev Drug Discov. 2005;4 (11):919-27. (Pubitemid 41637694)
29. Galandrin S, Oligny-Longpre G, Bouvier M. The evasive nature of drug efficacy: Implications for drug discovery. Trends Pharmacol Sci. 2007;28(8):423-30. (Pubitemid 47087968)
30. Kenakin T. Collateral efficacy in drug discovery: Taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci. 2007;28(8):407-15. (Pubitemid 47087972)
31. Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends MolMed. 2011.
32. Arey BJ, Stevis PE, Deecher DC, Shen ES, Frail DE, Negro-Vilar A, et al. Induction of promiscuous G protein coupling of the folliclestimulating hormone (FSH) receptor: A novel mechanism for transducing pleiotropic actions of FSH isoforms. Mol Endocrinol. 1997;11(5):517-26. (Pubitemid 27193788)
33. Crepieux P, Marion S, Martinat N, Fafeur V, Vern YL, Kerboeuf D, et al. The ERK-dependent signalling is stage-specifically modulated by FSH, during primary Sertoli cell maturation. Oncogene. 2001;20(34):4696-709. (Pubitemid 32762441)
34. Quintana J, Hipkin RW, Sanchez-Yague J, Ascoli M. Follitropin (FSH) and a phorbol ester stimulate the phosphorylation of the FSH receptor in intact cells. J Biol Chem. 1994;269(12):8772-9. (Pubitemid 24209186)
35. Lin YF, Tseng MJ, Hsu HL, Wu YW, Lee YH, Tsai YH. A novel follicle-stimulating hormone-induced G alpha h/phospholipase C-delta1 signaling pathway mediating rat sertoli cell Ca2+-influx. Mol Endocrinol. 2006;20(10):2514-27.
36. Gilchrist RL, Ryu KS, Ji I, Ji TH. The luteinizing hormone/ chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. J Biol Chem. 1996;271(32):19283-7. (Pubitemid 26271596)
37. Moraga PF, Llanos MN, Ronco AM. Arachidonic acid release from rat Leydig cells depends on the presence of luteinizing hormone/human chorionic gonadotrophin receptors. J Endocrinol. 1997;154(2):201-9. (Pubitemid 27330632)
38. Ronco AM, Moraga PF, Llanos MN. Arachidonic acid release from rat Leydig cells: The involvement of G protein, phospholipase A2 and regulation of cAMP production. J Endocrinol. 2002;172(1):95-104. (Pubitemid 34082948)
39. Zeleznik AJ, Saxena D, Little-Ihrig L. Protein kinase B is obligatory for follicle-stimulating hormone-induced granulosa cell differentiation. Endocrinology. 2003;144(9):3985-94. (Pubitemid 37088754)
40. Gonzalez-Robayna IJ, Falender AE, Ochsner S, Firestone GL, Richards JS. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): Evidence for A kinase-independent signaling by FSH in granulosa cells. Mol Endocrinol. 2000;14(8):1283-300. (Pubitemid 32260488)
41. Wayne CM, Fan HY, Cheng X, Richards JS. Follicle-stimulating hormone induces multiple signaling cascades: Evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol Endocrinol. 2007;21(8):1940-57. (Pubitemid 47173802)
42. Escamilla-Hernandez R, Little-Ihrig L, Orwig KE, Yue J, Chandran U, Zeleznik AJ. Constitutively active protein kinase A qualitatively mimics the effects of follicle-stimulating hormone on granulosa cell differentiation. Mol Endocrinol. 2008;22 (8):1842-52.
43. Scobey M, Bertera S, Somers J, Watkins S, Zeleznik A, Walker W. Delivery of a cyclic adenosine 3',5'-monophosphate response element-binding protein (creb) mutant to seminiferous tubules results in impaired spermatogenesis. Endocrinology. 2001;142 (2):948-54. (Pubitemid 32222445)
44. Salvador LM, Park Y, Cottom J, Maizels ET, Jones JC, Schillace RV, et al. Follicle-stimulating hormone stimulates protein kinase A-mediated histone H3 phosphorylation and acetylation leading to select gene activation in ovarian granulosa cells. J Biol Chem. 2001;276(43):40146-55.
45. Kang J, Shi Y, Xiang B, Qu B, Su W, Zhu M, et al. A nuclear function of beta-arrestin1 in GPCR signaling: Regulation of histone acetylation and gene transcription. Cell. 2005;123 (5):833-47. (Pubitemid 41721030)
46. Kovacs JJ, Hara MR, Davenport CL, Kim J, Lefkowitz RJ. Arrestin development: Emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell. 2009;17(4):443-58.
47. Marion S, Kara E, Crepieux P, Piketty V, Martinat N, Guillou F, et al. G protein-coupled receptor kinase 2 and beta-arrestins are recruited to FSH receptor in stimulated rat primary Sertoli cells. J Endocrinol. 2006;190(2):341-50. (Pubitemid 44288371)
48. Marion S, Robert F, Crepieux P, Martinat N, Troispoux C, Guillou F, et al. G protein-coupled receptor kinases and beta arrestins are relocalized and attenuate cyclic 3',5'-adenosine monophosphate response to follicle-stimulating hormone in rat primary Sertoli cells. Biol Reprod. 2002;66(1):70-6. (Pubitemid 34020589)
49. Kara E, Crepieux P, Gauthier C, Martinat N, Piketty V, Guillou F, et al. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestinmediated ERK activation. Mol Endocrinol. 2006;20(11):3014-26. (Pubitemid 44833552)
50. Wehbi V, Decourtye J, Piketty V, Durand G, Reiter E, Maurel MC. Selective modulation of follicle-stimulating hormone signaling pathways with enhancing equine chorionic gonadotropin/ antibody immune complexes. Endocrinology. 2010;151 (6):2788-99.
51. Wehbi V, Tranchant T, Durand G, Musnier A, Decourtye J, Piketty V, et al. Partially deglycosylated equine LH preferentially activates beta-arrestin-dependent signaling at the folliclestimulating hormone receptor. Mol Endocrinol. 2010;24 (3):561-73.
52. Tranchant T, Durand G, Gauthier C, Crepieux P, Ulloa-Aguirre A, Royere D, et al. Preferential beta-arrestin signalling at low receptor density revealed by functional characterization of the human FSH receptor A189 V mutation. Mol Cell Endocrinol. 2011;331(1):109-18.
53. Lécureuil C, Tesseraud S, Kara E, Martinat N, Sow A, Fontaine I, et al. Follicle-stimulating hormone activates p70 ribosomal protein S6 kinase by protein kinase A-mediated dephosphorylation of Thr 421/Ser 424 in primary Sertoli cells. Mol Endocrinol. 2005;19(7):1812-20. (Pubitemid 41007893)
54. Musnier A, Boulo T, Reiter E, Morales J, Oulhen N, Dupuy L et al. FSH signalling acts at multiple levels to regulate mRNA translation. submitted.
55. Musnier A, Heitzler D, Boulo T, Tesseraud S, Durand G, Lecureuil C, et al. Developmental regulation of p70 S6 kinase by a G protein-coupled receptor dynamically modelized in primary cells. Cell Mol Life Sci. 2009;66(21):3487-503.
56. Alam H, Maizels ET, Park Y, Ghaey S, Feiger ZJ, Chandel NS, et al. FSH activation of HIF-1 by the PI3-kinase/AKT/Rheb/ mTOR pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem. 2004;279 (19):19431-40.
57. Alam H,Weck J, Maizels E, Park Y, Lee EJ, AshcroftM, et al. Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)- 1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone. Endocrinology. 2009;150(2):915-28.
58. Kayampilly PP, Menon KM. Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells. Endocrinology. 2007;148(8):3950-7. (Pubitemid 47105853)
59. Kayampilly PP, Menon KM. Follicle-stimulating hormone inhibits adenosine 5'-monophosphate-activated protein kinase activation and promotes cell proliferation of primary granulosa cells in culture through an Akt-dependent pathway. Endocrinology. 2009;150(2):929-35.
60. Hou X, Arvisais EW, Davis JS. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: Modulation of glycogen synthase kinase 3 and AMPactivated protein kinase. Endocrinology. 2010;151(6):2846-57.
61. Fan HY, O'Connor A, Shitanaka M, Shimada M, Liu Z, Richards JS. Beta-catenin (CTNNB1) promotes preovulatory follicular development but represses LH-mediated ovulation and luteinization. Mol Endocrinol. 2011;24(8):1529-42.
62. Rosano L, Cianfrocca R, Masi S, Spinella F, Di Castro V, Biroccio A, et al. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci USA. 2009;106(8):2806-11.
63. Xiao K, Sun J, Kim J, Rajagopal S, Zhai B, Villen J, et al. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc Natl Acad Sci USA. 2010;107(34):15299-304.
64. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 1999;283(5402):655-61.
65. Goel R, Phillips-Mason PJ, Raben DM, Baldassare JJ. alpha- Thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression. J Biol Chem. 2002;277(21):18640-8. (Pubitemid 34952419)
66. Lodeiro M, Theodoropoulou M, Pardo M, Casanueva FF, Camina JP. c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms. PLoS ONE. 2009;4(3):e4686.
67. Schmid CL, Bohn LM. Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ss-arrestin2/Src/Akt signaling complex in vivo. J Neurosci. 2010;30(40):13513-24.
68. Nechamen CA, Thomas RM, Cohen BD, Acevedo G, Poulikakos PI, Testa JR, et al. Human follicle-stimulating hormone (FSH) receptor interacts with the adaptor protein APPL1 in HEK 293 cells: Potential involvement of the PI3K pathway in FSH signaling. Biol Reprod. 2004;71(2):629-36. (Pubitemid 38970540)
69. Liu Z, Rudd MD, Hernandez-Gonzalez I, Gonzalez-Robayna I, Fan HY, Zeleznik AJ, et al. FSH and FOXO1 regulate genes in the sterol/steroid and lipid biosynthetic pathways in granulosa cells. Mol Endocrinol. 2009;23(5):649-61.
70. Thomas RM, Nechamen CA, Mzurkiewicz JE, Ulloa-Aguirre A, Dias JA. The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca2+ mobilization. Endocrinology. 2011;152 (4):1691-1701.
71. Kim J, Ahn S, Ren XR, Whalen EJ, Reiter E, Wei H, et al. Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci USA. 2005;102(5):1442-7.
72. Ren XR, Reiter E, Ahn S, Kim J, ChenW, Lefkowitz RJ. Different G protein-coupled receptor kinases govern G protein and betaarrestin- mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci USA. 2005;102(5):1448-53. (Pubitemid 40209190)
73. Mukherjee S, Gurevich VV, Jones JC, Casanova JE, Frank SR, Maizels ET, et al. The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization. Proc Natl Acad Sci USA. 2000;97(11):5901-6.
74. Zhang Q, Bhola NE, Lui VW, Siwak DR, Thomas SM, Gubish CT, et al. Antitumor mechanisms of combined gastrinreleasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer. Mol Cancer Ther. 2007;6(4):1414-24. (Pubitemid 46712005)
75. Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science. 2004;303(5658):682-4. (Pubitemid 38141636)
76. Turner CE, Brown MC. Cell motility: ARNO and ARF6 at the cutting edge. Curr Biol. 2001;11(21):R875-7. (Pubitemid 33037772)
77. Wang X, Walsh LP, Reinhart AJ, Stocco DM. The role of arachidonic acid in steroidogenesis and steroidogenic acute regulatory (StAR) gene and protein expression. J Biol Chem. 2000;275(26):20204-9. (Pubitemid 30441632)
78. Fan QR, Hendrickson WA. Structure of human folliclestimulating hormone in complex with its receptor. Nature. 2005;433(7023):269-77.
79. Arey BJ, Deecher DC, Shen ES, Stevis PE, Meade Jr. EH, Wrobel J, et al. Identification and characterization of a selective, nonpeptide follicle-stimulating hormone receptor antagonist. Endocrinology. 2002;143(10):3822-9. (Pubitemid 35244361)
80. Wrobel J, Green D, Jetter J, Kao W, Rogers J, Perez MC, et al. Synthesis of (bis)sulfonic acid, (bis)benzamides as folliclestimulating hormone (FSH) antagonists. Bioorg Med Chem. 2002;10(3):639-56.
81. Guo T, Adang AE, Dolle RE, Dong G, Fitzpatrick D, Geng P, et al. Small molecule biaryl FSH receptor agonists. Part 1: Lead discovery via encoded combinatorial synthesis. Bioorg Med Chem Lett. 2004;14(7):1713-6. (Pubitemid 38340672)
82. Guo T, Adang AE, Dong G, Fitzpatrick D, Geng P, Ho KK, et al. Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesis. Bioorg Med Chem Lett. 2004;14(7):1717-20. (Pubitemid 38340673)
83. van Straten NC, van Berkel TH, Demont DR, Karstens WJ, Merkx R, Oosterom J, et al. Identification of substituted 6- amino-4-phenyltetrahydroquinoline derivatives: Potent antagonists for the follicle-stimulating hormone receptor. J Med Chem. 2005;48(6):1697-700. (Pubitemid 40396299)
84. Yanofsky SD, Shen ES, Holden F, Whitehorn E, Aguilar B, Tate E, et al. Allosteric activation of the follicle-stimulating hormone (FSH) receptor by selective, nonpeptide agonists. J Biol Chem. 2006;281(19):13226-33. (Pubitemid 43855234)
85. Arey BJ, Yanofsky SD, Claudia Perez M, Holmes CP, Wrobel J, Gopalsamy A, et al. Differing pharmacological activities of thiazolidinone analogs at the FSH receptor. Biochem Biophys Res Commun. 2008;368(3):723-8.
86. Dias JA, Bonnet B, Weaver BA, Watts J, Kluetzman K, Thomas RM et al. A negative allosteric modulator demonstrates biased antagonism of the follicle stimulating hormone receptor. Molecular and cellular endocrinology. 2011.
87. Maclean D, Holden F, Davis AM, Scheuerman RA, Yanofsky S, Holmes CP, et al. Agonists of the follicle stimulating hormone receptor from an encoded thiazolidinone library. J Comb Chem. 2004;6(2):196-206. (Pubitemid 38453146)
88. van Straten NC, Schoonus-Gerritsma GG, van Someren RG, Draaijer J, Adang AE, Timmers CM, et al. The first orally active low molecular weight agonists for the LH receptor: Thienopyr (im)idines with therapeutic potential for ovulation induction. Chembiochem. 2002;3(10):1023-6. (Pubitemid 35177756)
89. Jorand-Lebrun C, Brondyk B, Lin J, Magar S, Murray R, Reddy A, et al. Identification, synthesis, and biological evaluation of novel pyrazoles as low molecular weight luteinizing hormone receptor agonists. Bioorg Med Chem Lett. 2007;17(7):2080-5. (Pubitemid 46367648)
90. Arey BJ. Allosteric modulators of glycoprotein hormone receptors: Discovery and therapeutic potential. Endocr. 2008;34(1-3):1-10.
91. Janovick JA, Maya-Nunez G, Ulloa-Aguirre A, Huhtaniemi IT, Dias JA, Verbost P, et al. Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine. Mol Cell Endocrinol. 2009;298(1-2):84-8.
92. May LT, Leach K, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol. 2007;47:1-51. (Pubitemid 46277033)
93. Schwartz TW, Frimurer TM, Holst B, Rosenkilde MM, Elling CE. Molecular mechanism of 7TM receptor activation-a global toggle switch model. Annu Rev Pharmacol Toxicol. 2006;46:481-519. (Pubitemid 43271198)
94. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature. 2007;450 (7168):383-7. (Pubitemid 350126755)
95. Ferasin L, Gabai G, Beattie J, Bono G, Holder AT. Enhancement of FSH bioactivity in vivo using site-specific antisera. J Endocrinol. 1997;152(3):355-63. (Pubitemid 27102199)
96. Glencross RG, Lovell RD, Holder AT. Monoclonal antibody enhancement of FSH-induced uterine growth in snell dwarf mice. J Endocrinol. 1993;136(3):R5-7. (Pubitemid 23142199)
97. Holder AT, Aston R, Preece MA, Ivanyi J. Monoclonal antibodymediated enhancement of growth hormone activity in vivo. J Endocrinol. 1985;107(3):R9-12. (Pubitemid 16211168)
98. Holder AT, Aston R, Rest JR, Hill DJ, Patel N, Ivanyi J. Monoclonal antibodies can enhance the biological activity of thyrotropin. Endocrinology. 1987;120(2):567-73. (Pubitemid 17020409)
99. Aston R, Holder AT, Ivanyi J, Bomford R. Enhancement of bovine growth hormone activity in vivo by monoclonal antibodies. Mol Immunol. 1987;24(2):143-50. (Pubitemid 17018031)
100. Pell JM, Johnsson ID, Pullar RA, Morrell DJ, Hart IC, Holder AT, et al. Potentiation of growth hormone activity in sheep using monoclonal antibodies. J Endocrinol. 1989;120(2):R15-8. (Pubitemid 19042728)
101. Boyman O, Surh CD, Sprent J. Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert Opin Biol Ther. 2006;6(12):1323-31. (Pubitemid 44875686)
102. Boyman O, Ramsey C, Kim DM, Sprent J, Surh CD. IL-7/anti- IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia. J Immunol. 2008;180(11):7265-75.
103. Herve V, Roy F, Bertin J, Guillou F, Maurel MC. Antiequine chorionic gonadotropin (eCG) antibodies generated in goats treated with eCG for the induction of ovulation modulate the luteinizing hormone and follicle-stimulating hormone bioactivities of eCG differently. Endocrinology. 2004;145(1):294-303. (Pubitemid 38094523)
104. Bishop LA, Robertson DM, Cahir N, Schofield PR. Specific roles for the asparagine-linked carbohydrate residues of recombinant human follicle stimulating hormone in receptor binding and signal transduction. Mol Endocrinol. 1994;8(6):722-31. (Pubitemid 24179664)
105. Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science. 2001;291(5512):2364-9. (Pubitemid 32231791)
106. Ulloa-Aguirre A, Timossi C, Damian-Matsumura P, Dias JA. Role of glycosylation in function of follicle-stimulating hormone. Endocr. 1999;11(3):205-15. (Pubitemid 30163330)
107. Matzuk MM, Boime I. Site-specific mutagenesis defines the intracellular role of the asparagine-linked oligosaccharides of chorionic gonadotropin beta subunit. J Biol Chem. 1988;263 (32):17106-11. (Pubitemid 18268899)
108. Matzuk MM, Boime I. The role of the asparagine-linked oligosaccharides of the alpha subunit in the secretion and assembly of human chorionic gonadotrophin. J Cell Biol. 1988;106(4):1049-59.
109. Matzuk MM, Boime I. Mutagenesis and gene transfer define site-specific roles of the gonadotropin oligosaccharides. Biol Reprod. 1989;40(1):48-53. (Pubitemid 19072695)
110. Matzuk MM, Hsueh AJ, Lapolt P, Tsafriri A, Keene JL, Boime I. The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] beta-subunit. Endocrinology. 1990;126(1):376-83. (Pubitemid 20037166)
111. Muyan M, Boime I. The carboxyl-terminal region is a determinant for the intracellular behavior of the chorionic gonadotropin beta subunit: Effects on the processing of the Asn-linked oligosaccharides. Mol Endocrinol. 1998;12(5):766-72. (Pubitemid 30659077)
112. Sairam MR, Bhargavi GN. A role for glycosylation of the alpha subunit in transduction of biological signal in glycoprotein hormones. Science. 1985;229(4708):65-7. (Pubitemid 15018281)
113. Sairam MR. Role of carbohydrates in glycoprotein hormone signal transduction. FASEB J. 1989;3(8):1915-26. (Pubitemid 19152578)
114. Smith PL, Kaetzel D, Nilson J, Baenziger JU. The sialylated oligosaccharides of recombinant bovine lutropin modulate hormone bioactivity. J Biol Chem. 1990;265(2):874-81.
115. Baenziger JU, Green ED. Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. Biochim Biophys Acta. 1988;947(2):287-306.
116. Bousfield GR, Butnev VY, Gotschall RR, Baker VL, Moore WT. Structural features of mammalian gonadotropins. Mol Cell Endocrinol. 1996;125(1-2):3-19. (Pubitemid 27037780)
117. Bousfield GR, Butnev VY, Walton WJ, Nguyen VT, Huneidi J, Singh V, et al. All-or-none N-glycosylation in primate folliclestimulating hormone beta-subunits. Mol Cell Endocrinol. 2007;260-262:40-8. (Pubitemid 44792352)
118. Walton WJ, Nguyen VT, Butnev VY, Singh V, Moore WT, Bousfield GR. Characterization of human FSH isoforms reveals a nonglycosylated beta-subunit in addition to the conventional glycosylated beta-subunit. J Clin Endocrinol Metab. 2001;86 (8):3675-85. (Pubitemid 32755960)
119. Green ED, Boime I, Baenziger JU. Differential processing of Asn-linked oligosaccharides on pituitary glycoprotein hormones: Implications for biologic function. Mol Cell Biochem. 1986;72 (1-2):81-100. (Pubitemid 17220756)
120. Renwick AG, Mizuochi T, Kochibe N, Kobata A. The asparagine-linked sugar chains of human follicle-stimulating hormone. J Biochem. 1987;101(5):1209-21. (Pubitemid 17060307)
121. Green ED, Baenziger JU. Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. II. Distributions of sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones. J Biol Chem. 1988;263(1):36-44. (Pubitemid 18041039)
122. Green ED, Baenziger JU. Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. I. Structural elucidation of the sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones. J Biol Chem. 1988;263(1):25-35. (Pubitemid 18041038)
123. Weisshaar G, Hiyama J, Renwick AG, Nimtz M. NMR investigations of the N-linked oligosaccharides at individual glycosylation sites of human lutropin. Eur J Biochem/FEBS. 1991;195(1):257-68.
124. Weisshaar G, Hiyama J, Renwick AG. Site-specific N-glycosylation of human chorionic gonadotrophin-structural analysis of glycopeptides by one- and two-dimensional 1H NMR spectroscopy. Glycobiology. 1991;1(4):393-404.
125. Dalpathado DS, Irungu J, Go EP, Butnev VY, Norton K, Bousfield GR, et al. Comparative glycomics of the glycoprotein follicle stimulating hormone: Glycopeptide analysis of isolates from two mammalian species. Biochemistry. 2006;45(28):8665-73. (Pubitemid 44078887)
126. Muyan M, Ruddon RW, Norton SE, Boime I, Bedows E. Dissociation of early folding events from assembly of the human lutropin beta-subunit. Mol Endocrinol. 1998;12(10):1640-9.
127. Bousfield GR, Butnev VY, Bidart JM, Dalpathado D, Irungu J, Desaire H. Chromatofocusing fails to separate hFSH isoforms on the basis of glycan structure. Biochemistry. 2008;47(6):1708-20. (Pubitemid 351231220)
128. Ulloa-Aguirre A, Midgley Jr. AR, Beitins IZ, Padmanabhan V. Follicle-stimulating isohormones: Characterization and physiological relevance. Endocr Rev. 1995;16(6):765-87.
129. Birken S, Maydelman Y, Gawinowicz MA, Pound A, Liu Y, Hartree AS. Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology. 1996;137(4):1402-11. (Pubitemid 26095259)
130. Olivares A, Cardenas M, Timossi C, Zarinan T, Diaz-Sanchez V, Ulloa-Aguirre A. Reactivity of different LH and FSH standards and preparations in the world health organization matched reagents for enzyme-linked immunoassays of gonadotrophins. Hum Reprod. 2000;15(11):2285-91.
131. Stanton PG, Burgon PG, Hearn MT, Robertson DM. Structural and functional characterisation of hFSH and hLH isoforms. Mol Cell Endocrinol. 1996;125(1-2):133-41. (Pubitemid 27037792)
132. Wide L, Bakos O. More basic forms of both human folliclestimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase. J Clin Endocrinol Metab. 1993;76(4):885-9. (Pubitemid 23110832)
133. Bishop LA, Nguyen TV, Schofield PR. Both of the beta-subunit carbohydrate residues of follicle-stimulating hormone determine the metabolic clearance rate and in vivo potency. Endocrinology. 1995;136(6):2635-40.
134. Matzuk MM, Keene JL, Boime I. Site specificity of the chorionic gonadotropin N-linked oligosaccharides in signal transduction. J Biol Chem. 1989;264(5):2409-14. (Pubitemid 19057723)
135. Valove FM, Finch C, Anasti JN, Froehlich J, Flack MR. Receptor binding and signal transduction are dissociable functions requiring different sites on follicle-stimulating hormone. Endocrinology. 1994;135(6):2657-61. (Pubitemid 24377429)
136. Bousfield GR, Butnev VY, Butnev VY, Nguyen VT, Gray CM, Dias JA, et al. Differential effects of alpha subunit Asparagine56 oligosaccharide structure on equine lutropin and follitropin hybrid conformation and receptor-binding activity. Biochemistry. 2004;43(33):10817-33. (Pubitemid 39096724)
137. Flack MR, Froehlich J, Bennet AP, Anasti J, Nisula BC. Sitedirected mutagenesis defines the individual roles of the glycosylation sites on follicle-stimulating hormone. J Biol Chem. 1994;269(19):14015-20. (Pubitemid 24191153)
138. Nguyen VT, Singh V, Butnev VY, Gray CM, Westfall S, Davis JS, et al. Inositol phosphate stimulation by LH requires the entire alpha Asn56 oligosaccharide. Mol Cell Endocrinol. 2003;199(1- 2):73-86. (Pubitemid 36170293)
139. Rebois RV, Liss MT. Antibody binding to the beta-subunit of deglycosylated chorionic gonadotropin converts the antagonist to an agonist. J Biol Chem. 1987;262(8):3891-6. (Pubitemid 17136451)
140. Butney VY, Gotschall RR, Butnev VY, Baker VL, Moore WT, Bousfield GR. Hormone-specific inhibitory influence of alphasubunit Asn56 oligosaccharide on in vitro subunit association and follicle-stimulating hormone receptor binding of equine gonadotropins. Biol Reprod. 1998;58(2):458-69. (Pubitemid 28099112)
141. Fox KM, Dias JA, Van Roey P. Three-dimensional structure of human follicle-stimulating hormone. Mol Endocrinol (Baltim, Md). 2001;15(3):378-89. (Pubitemid 32221915)
142. Dias JA, Van Roey P. Structural biology of human follitropin and its receptor. Arch Med Res. 2001;32(6):510-9. (Pubitemid 34031743)
143. Fan QR, Hendrickson WA. Structural biology of glycoprotein hormones and their receptors. Endocr. 2005;26(3):179-88. (Pubitemid 41271083)
144. Butnev VY, Singh V, Nguyen VT, Bousfield GR. Truncated equine LH beta and asparagine(56)-deglycosylated equine LH alpha combine to produce a potent FSH antagonist. J Endocrinol. 2002;172(3):545-55. (Pubitemid 34232696)
145. Ulloa-Aguirre A, Timossi C, Barrios-de-Tomasi J, Maldonado A, Nayudu P. Impact of carbohydrate heterogeneity in function of follicle-stimulating hormone: Studies derived from in vitro and in vivo models. Biol Reprod. 2003;69(2):379-89. (Pubitemid 36885939)
146. Yding Andersen C, Leonardsen L, Ulloa-Aguirre A, Barrios-De- Tomasi J, Moore L, Byskov AG. FSH-induced resumption of meiosis in mouse oocytes: Effect of different isoforms. Mol Hum Reprod. 1999;5(8):726-31. (Pubitemid 29366869)
147. Andersen CY, Leonardsen L, Ulloa-Aguirre A, Barrios-De-Tomasi J, Kristensen KS, Byskov AG. Effect of different FSH isoforms on cyclic-AMP production by mouse cumulus-oocyte-complexes: A time course study. Mol Hum Reprod. 2001;7(2):129-35. (Pubitemid 32148339)
148. Barrios-de-Tomasi J, Nayudu PL, Brehm R, Heistermann M, Zarinan T, Ulloa-Aguirre A. Effects of human pituitary FSH isoforms on mouse follicles in vitro. Reprod Biomed Online. 2006;12(4):428-41.
149. Timossi CM, Barrios de Tomasi J, Zambrano E, Gonzalez R, Ulloa- Aguirre A. A naturally occurring basically charged human folliclestimulating hormone (FSH) variant inhibits FSH-induced androgen aromatization and tissue-type plasminogen activator enzyme activity in vitro. Neuroendocrinology. 1998;67((3):153-63. (Pubitemid 28112391)
150. Timossi CM, Barrios-de-Tomasi J, Gonzalez-Suarez R, Arranz MC, Padmanabhan V, Conn PM, et al. Differential effects of the charge variants of human follicle-stimulating hormone. J Endocrinol. 2000;165(2):193-205. (Pubitemid 30341068)
151. Vaidehi N, Kenakin T. The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Curr Opin Pharmacol. 10(6):775-81.
152. Creus S, Chaia Z, Pellizzari EH, Cigorraga SB, Ulloa-Aguirre A, Campo S. Human FSH isoforms: Carbohydrate complexity as determinant of in-vitro bioactivity. Mol Cell Endocrinol. 2001;174 (1-2):41-9. (Pubitemid 32288867)
153. Ulloa-Aguirre A, Timossi C. Biochemical and functional aspects of gonadotrophin-releasing hormone and gonadotrophins. Reprod Biomed Online. 2000;1(2):48-62.
154. Stanton PG, Pozvek G, Burgon PG, Robertson DM, Hearn MT. Isolation and characterization of human LH isoforms. J Endocrinol. 1993;138(3):529-43. (Pubitemid 23343081)
155. Stanton PG, Robertson DM, Burgon PG, Schmauk-White B, Hearn MT. Isolation and physicochemical characterization of human follicle-stimulating hormone isoforms. Endocrinology. 1992;130(5):2820-32.
156. Baenziger JU. Glycoprotein hormone GalNAc-4-sulphotransferase. Biochem Soc Trans. 2003;31(2):326-30. (Pubitemid 36520667)
157. Schaaf L, Leiprecht A, Saji M, Hubner U, Usadel KH, Kohn LD. Glycosylation variants of human TSH selectively activate signal transduction pathways. Mol Cell Endocrinol. 1997;132(1-2):185-94. (Pubitemid 27420313)
158. Ulloa-Aguirre A, Timossi C, Mendez JP. Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans? I. Gondatrophins are synthesized and released in multiple molecular forms. A matter of fact. Hum Reprod. 2001;16(4):599-604. (Pubitemid 32293779)
159. Vaidehi N. Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design. Drug Discov Today. 2010;15(21-22):951-7.
160. Kenakin T. Inverse, protean, and ligand-selective agonism: Matters of receptor conformation. FASEB J. 2001;15(3):598-611. (Pubitemid 32245978)
161. Aggarwal BB, Lictt P, Papkoff H, Bona-Gallo A. Interaction of equine luteinizing hormone with binding sites for folliclestimulating hormone in the rat seminiferous tubule. Endocrinology. 1980;107(3):725-31. (Pubitemid 10056565)
162. Trousdale RK, Yu B, Pollak SV, Husami N, Vidali A, Lustbader JW. Efficacy of native and hyperglycosylated follicle-stimulating hormone analogs for promoting fertility in female mice. Fertil Steril. 2009;91(1):265-70.
163. Weenen C, Pena JE, Pollak SV, Klein J, Lobel L, Trousdale RK, et al. Long-acting follicle-stimulating hormone analogs containing N-linked glycosylation exhibited increased bioactivity compared with o-linked analogs in female rats. J Clin Endocrinol Metab. 2004;89(10):5204-12. (Pubitemid 39391470)
164. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol. 2002;16(4):736-46. (Pubitemid 34297743)
165. Vassart G, Pardo L, Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci. 2004;29 (3):119-26. (Pubitemid 38314857)
166. Kitano H, Funahashi A, Matsuoka Y, Oda K. Using process diagrams for the graphical representation of biological networks. Nat Biotechnol. 2005;23(8):961-6. (Pubitemid 41114029)
167. Eswar N,Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics. 2006;Chapter 5:Unit 5 6.
168. Okada T, Sugihara M, Bondar AN, Elstner M, Entel P, Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol. 2004;342 (2):571-83. (Pubitemid 39149759)